pembrolizumab
merck
['bcsm', 'breast', 'pembro', 'mbc']
phase iia study of dc1 vaccines targeting her2/her3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or her2+ breast cancer. #mbc #bcsm #metastaticbreastcancer #asco23 #denovombc #clinicaltrials 